Finance

Lists
4118:TYO
Kaneka Corp
JP¥5 960,00
-1,50%
(-91,00) 1D
2 Okt., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4118...
Open
JP¥6 010
High
JP¥6 034
Low
JP¥5 937
Mkt. cap
375,48 mjd
Avg. vol.
221,53 k
Volume
182,30 k
Dividend
2,68%
Quarterly dividend
JPÂ¥40
Ex-dividend date
29 Sep. 2026
P/E ratio
10,22
52-wk high
JP¥6 570
52-wk low
JP¥4 082
EPS
JPÂ¥583
Shares outstanding
65,56 m
No. of employees
12 k
Open
JP¥6 010
High
JP¥6 034
Low
JP¥5 937
Mkt. cap
375,48 mjd
Avg. vol.
221,53 k
Volume
182,30 k
Dividend
2,68%
Quarterly dividend
JPÂ¥40
Ex-dividend date
29 Sep. 2026
P/E ratio
10,22
52-wk high
JP¥6 570
52-wk low
JP¥4 082
EPS
JPÂ¥583
Shares outstanding
65,56 m
No. of employees
12 k
News stories
From web sources and news partners
Profile
Kaneka Corporation is a Japanese international chemical manufacturing company based in Osaka. The company was founded in 1949 and produces chemical products such as functional resin, foam resin, and synthetic fibers. The company was also engaged in the medical equipment business. In recent years, the company manufactured raw material for production of coenzyme Q10, and apheresis devices, where blood of a donor or patient is passed through an apparatus that separates out one particular constituent and returns the remainder to the circulation. Wikipedia
About Kaneka Corp
CEO-
Employees11,8 k
Founded01 Sep. 1949
Headquarters-
SectorCommodity chemical
Last report
13 Aug. 2026
Fiscal period
Q1 2027
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
223,02 mjd / 205,80 mjd
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
198,75 mjd
200,85 mjd
213,36 mjd
223,02 mjd
Cost of goods sold
144,43 mjd
144,80 mjd
152,38 mjd
157,45 mjd
Cost of revenue
144,43 mjd
144,80 mjd
152,38 mjd
157,45 mjd
Research and development expenses
-
-
39,89 mjd
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
47,51 mjd
48,81 mjd
847,00 m
50,64 mjd
Operating expense
47,51 mjd
48,81 mjd
51,54 mjd
50,64 mjd
Total operating expenses
191,94 mjd
193,62 mjd
203,92 mjd
208,08 mjd
Operating income
6,80 mjd
7,23 mjd
9,44 mjd
14,94 mjd
Other non operating income
-332,00 m
-340,00 m
1,29 mjd
-222,00 m
EBT including unusual items
9,96 mjd
11,33 mjd
16,62 mjd
13,42 mjd
EBT excluding unusual items
6,27 mjd
7,98 mjd
10,87 mjd
14,69 mjd
Income tax expense
2,74 mjd
3,58 mjd
3,60 mjd
3,92 mjd
Effective tax rate
27,56%
31,57%
21,67%
29,24%
Other operating expenses
-
-
-
-
Net income
6,79 mjd
7,39 mjd
12,54 mjd
8,94 mjd
Net profit margin
3,42%
3,68%
5,88%
4,01%
Earnings per share
-
-
-
-
Interest and investment income
235,00 m
771,00 m
385,00 m
675,00 m
Interest expense
-1,01 mjd
-1,00 mjd
-1,07 mjd
-1,09 mjd
Net interest expenses
-775,00 m
-229,00 m
-682,00 m
-419,00 m
Depreciation and amortization charges
-
-
10,80 mjd
-
EBITDA
18,40 mjd
18,22 mjd
21,30 mjd
26,80 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme